CPIX · Categories · Form 4

CPIX - SEC Form 4 insider transactions

Cumberland Pharmaceuticals Inc. (CPIX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CPIX

• 80d
  SEC Form 4 filed by Brown Martin S Jr

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Galante Joseph C

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Jones James

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Krogulski Kenneth

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Young Caroline

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Anthony Todd M.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Bitterman Chris T.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Hamm John M.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Herman James L

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Kazimi A J

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 82d
  SEC Form 4 filed by Kazimi A J

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 153d
  Director Young Caroline increased direct ownership by 0.20% to 33,309 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 153d
  Director Jones James increased direct ownership by 0.60% to 45,063 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 153d
  Chairman and CEO Kazimi A J increased direct ownership by 0.00% to 5,701,155 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 153d
  Director Krogulski Kenneth increased direct ownership by 0.65% to 296,538 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 189d
  Director Young Caroline increased direct ownership by 0.23% to 33,243 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 189d
  Director Jones James increased direct ownership by 0.68% to 44,793 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 189d
  Chairman and CEO Kazimi A J increased direct ownership by 0.01% to 5,700,885 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 189d
  Director Krogulski Kenneth increased direct ownership by 0.69% to 294,622 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 217d
  Director Young Caroline increased direct ownership by 0.42% to 33,168 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 217d
  Director Jones James increased direct ownership by 0.68% to 44,491 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 217d
  Chairman and CEO Kazimi A J increased direct ownership by 0.01% to 5,700,583 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 217d
  Director Krogulski Kenneth increased direct ownership by 0.54% to 292,595 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 248d
  Director Young Caroline increased direct ownership by 0.27% to 33,030 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 248d
  Director Jones James increased direct ownership by 0.58% to 44,192 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 248d
  Chairman and CEO Kazimi A J increased direct ownership by 0.00% to 5,700,284 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 248d
  Director Krogulski Kenneth increased direct ownership by 0.45% to 291,031 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Young Caroline was granted 1,000 shares, increasing direct ownership by 3% to 32,318 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Krogulski Kenneth was granted 5,000 shares, increasing direct ownership by 2% to 282,843 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Jones James was granted 1,000 shares, increasing direct ownership by 2% to 42,646 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Galante Joseph C was granted 1,000 shares, increasing direct ownership by 2% to 61,856 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Brown Martin S Jr was granted 1,000 shares, increasing direct ownership by 13% to 8,500 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  SEC Form 4 filed by VP and Chief Compliance Office Herman James L

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  SEC Form 4 filed by Vice Pres Sales & Marketing Bitterman Chris T.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  SEC Form 4 filed by Vice Pres Organizational Dev Anthony Todd M.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Chairman and CEO Kazimi A J covered exercise/tax liability with 3,558 shares, decreasing direct ownership by 0.06% to 5,698,738 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  VP Chief Financial Officer Hamm John M. covered exercise/tax liability with 5,930 shares, decreasing direct ownership by 23% to 20,073 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 494d
  Amendment: Director Brown Martin S Jr was granted 2,500 shares, increasing direct ownership by 50% to 7,500 units (SEC Form 4)

  4/A - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 494d
  Amendment: Director Galante Joseph C was granted 2,500 shares, increasing direct ownership by 4% to 60,856 units (SEC Form 4)

  4/A - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 494d
  Amendment: Director Jones James was granted 2,500 shares, increasing direct ownership by 6% to 41,646 units (SEC Form 4)

  4/A - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 494d
  Amendment: Director Krogulski Kenneth was granted 6,500 shares, increasing direct ownership by 2% to 277,843 units (SEC Form 4)

  4/A - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 494d
  Amendment: Director Young Caroline was granted 2,500 shares, increasing direct ownership by 9% to 31,318 units (SEC Form 4)

  4/A - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 613d
  Director Young Caroline increased direct ownership by 2% to 28,304 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 613d
  Director Jones James increased direct ownership by 3% to 36,445 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 613d
  Chairman and CEO Kazimi A J increased direct ownership by 0.02% to 5,698,595 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 613d
  Director Krogulski Kenneth increased direct ownership by 2% to 256,491 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 641d
  Director Young Caroline increased direct ownership by 1% to 27,858 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 641d
  Director Young Caroline increased direct ownership by 1% to 27,858 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 642d
  Director Krogulski Kenneth increased direct ownership by 2% to 252,027 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 642d
  Director Jones James increased direct ownership by 2% to 35,553 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 642d
  Chairman and CEO Kazimi A J increased direct ownership by 0.01% to 5,697,703 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 675d
  Director Krogulski Kenneth increased direct ownership by 2% to 247,907 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 675d
  Chairman and CEO Kazimi A J increased direct ownership by 0.02% to 5,696,881 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 675d
  Director Jones James increased direct ownership by 3% to 34,731 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 675d
  Director Young Caroline increased direct ownership by 2% to 27,456 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 706d
  Director Young Caroline increased direct ownership by 1% to 27,042 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 706d
  Director Krogulski Kenneth increased direct ownership by 0.94% to 243,557 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 706d
  Director Jones James increased direct ownership by 1% to 33,861 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 706d
  Chairman and CEO Kazimi A J increased direct ownership by 0.01% to 5,696,011 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 804d
  Krogulski Kenneth was granted 5,000 shares, increasing direct ownership by 2% to 241,277 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)

Other CPIX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends